---
layout: splash
title: 대웅 (003090)
excerpt: 대웅의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:의약품
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 24,750 | <span style="color: cornflowerblue">-2.6<small>%</small></span> | P:의약품 | 10.0 | 1.2 | 0.4<small>%</small> |

<!-- more -->

<br>
> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | P:의약품 / 의약품 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 지주회사/의약품, 화공약품, 농예약품, 위생용품, 의료용구, 식품, 전기전자기구, 부품 제조, 판매 |
| <span style="white-space:nowrap;">**상장**</span> | KOSPI / 1973년 6월 26일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 윤재춘 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.daewoong.com/](http://www.daewoong.com/){:target="_blank"} |

<br>
> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 02&#x2011;13 | | [매출액또는손익구조30%(대규모법인은15%)이상변경              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240213800578){:target="_blank"} |

<br>
> **주가 흐름**<a id="price"></a>

![003090](/stock/images/003090.png){: .align-center}

<br>
> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 24,750 | <span style="color: cornflowerblue">-2.6<small>%</small></span> | <span style="color: tomato">0.6<small>%</small></span> | <span style="color: tomato">23.4<small>%</small></span> | <span style="color: tomato">60.2<small>%</small></span> | <span style="color: tomato">77.0<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">33.4<small>%</small></span> | 41.4<small>%</small> | 0.81 | -37.7<small>%</small> | -16.5<small>%</small> | -0.9 |

<br>
> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:의약품 | 10.0 | 1.2 | 0.4<small>%</small> | - |

<br>

{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/003090/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=003090){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A003090&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=003090){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/003090){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/003090/financial-summary){:target="_blank"} |

<br>
> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![003090](/stock/images/003090_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 33.4<small>%</small> | 41.4<small>%</small> | 0.81 | -37.7<small>%</small> | -16.5<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 59.0<small>%</small> | 40.7<small>%</small> | 1.45 | -21.3<small>%</small> | -6.8<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | 2.2<small>%</small> | 30.1<small>%</small> | 0.07 | -26.0<small>%</small> | -10.2<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 33.0<small>%</small> | 29.6<small>%</small> | 1.12 | -18.4<small>%</small> | -8.1<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | 39.3<small>%</small> | 29.8<small>%</small> | 1.32 | -24.9<small>%</small> | -7.5<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | 62.2<small>%</small> | 33.5<small>%</small> | 1.86 | -17.0<small>%</small> | -2.9<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | 72.0<small>%</small> | 32.2<small>%</small> | 2.23 | -17.0<small>%</small> | -2.1<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 29.5<small>%</small> | 22.8<small>%</small> | 1.29 | -15.3<small>%</small> | -2.3<small>%</small> |
| MACD[^fn_tech_metric_macd] | 25.3<small>%</small> | 29.8<small>%</small> | 0.85 | -20.2<small>%</small> | -7.7<small>%</small> |

<br>
> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![003090](/stock/images/003090_corr.png){: .align-center}

|       | [휴젤](/145020/) | [삼성물산](/028260/) | [GS](/078930/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [삼성카드](/029780/) | [동국제약](/086450/) | [롯데웰푸드](/280360/) |

<br>
> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![003090](/stock/images/003090_2x.png){: .align-center}

<br>
> **관련 정보**

- [P:의약품 업종 목록](/stats/sector/kospi_업종_의약품_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}